GLMD icon

Galmed Pharmaceuticals
GLMD

Overview Fund Trends Analyst Outlook Journalist POV

16 hedge funds and large institutions have $429K invested in Galmed Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership: →

Holders
16
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$155K
2
+$155K
3
+$31.4K
4
Citadel Advisors
Citadel Advisors
Florida
+$25.1K
5
Two Sigma Investments
Two Sigma Investments
New York
+$19K

Top Sellers

1
-$261K
2
-$74.5K
3
-$152
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$155K
2
$155K
3
$31.4K
4
$25.1K
5
$19K
6
$18K
7
$12.5K
8
$12.4K
9
$1K
10
$126
11
$104
12
$32
13
$22
14
$17
15
$11
16
$5
17
$1
18
–
19
–
20
–